Login to Your Account

In The Clinic NEWS
With the FDA telling Sunesis Pharmaceuticals Inc. it wants additional clinical evidence on the experimental acute myeloid leukemia (AML) drug Qinprezo (vosaroxin) before backing submission of a new drug application (NDA), the company said it will "evaluate and refine" its U.S. plans while pursuing marketing approval for the drug in Europe, where regulators appear receptive to moving ahead with existing data.

DUBLIN – Further information on the first death of a cancer patient undergoing oncolytic viral therapy with a VSV strain engineered to express human interferon-β has emerged.

LONDON – A phase IIb placebo-controlled trial reported in The Lancet is the first to show clinical efficacy of a gene therapy in the treatment of CF.

More In The Clinic Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: